OxSonics, a medtech firm developing ultrasound therapies launched out of Oxford University in July last year, has secured £2.7m ($4.49m) in a venture round led by venture firm Longwall Venture Partners. The UK-based company’s technology uses ultrasound devices combined with ultrasound-sensitive nanoparticles, which can provide real-time feedback to a clinician about whether drug delivery or…
OxSonics sounds out £2.7m
Jan 24, 2014 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024